1. Home
  2. News
  3. Beijing Foyou Pharma Co., Ltd.
  4. (601089)"BEIJING FOYOU PHARMA CO., LTD."Report for Q3 2026
More Beijing Foyou Pharma Co., Ltd. news
Beijing Foyou Pharma Co., Ltd.SSE: 601089

(601089)"BEIJING FOYOU PHARMA CO., LTD."Report for Q3 2026

Oct 28, 2026 · Issued by Beijing Foyou Pharma Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 601089 · Oct 28, 2026 · 12 pages · Chinese

On 6ix: 6ix.com/news/601089beijing-foyou-pharma-co-ltdreport-for-q3-2026

Beijing Foyou Pharma Co., Ltd. on 6ix

Earlier from Beijing Foyou Pharma

  • (601089)"BEIJING FOYOU PHARMA CO., LTD."Announcement on Obtaining Drug Registration Certificate for Rotigotine PatchesOct 27
  • Announcement on Pledge of Shares Held by Persons Acting in Concert with the Controlling ShareholderSep 2
  • Announcement on Obtaining Drug Registration Certificate for Bromocriptine Mesylate TabletsAug 22
  • Announcement on the Completion of Raised-Fund Investment ProjectsAug 15
  • Announcement on Convening the 2026 Semi-annual Performance BriefingAug 12

Later from Beijing Foyou Pharma

  • (601089)"BEIJING FOYOU PHARMA CO., LTD."Indicative Announcement on Receipt of the Proposal for Share Repurchase from the ChairmanOct 29
All Beijing Foyou Pharma news releases↗

Follow Beijing Foyou Pharma into a list and get an email when it puts out news.

Follow Beijing Foyou Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer